Literature DB >> 9184702

Circulating CD8 T cells show increased interferon-gamma mRNA expression in HIV infection.

E C Breen1, J F Salazar-Gonzalez, L P Shen, J A Kolberg, M S Urdea, O Martinéz-Maza, J L Fahey.   

Abstract

IFN-gamma mRNA levels were measured in unstimulated PBMC and purified cell subpopulations, utilizing branched DNA assays, to characterize the cell type(s) that contribute to the in vivo increase in IFN-gamma gene expression seen in HIV infection. PBMC and CD8 T cells from HIV-seropositive subjects (HIV+) showed 2.5-fold increases in mean IFN-gamma mRNA levels compared to HIV-uninfected subjects (HIV-). Within individuals, CD8 T cells showed the highest IFN-gamma expression regardless of HIV status, which suggests that HIV infection enhances the IFN-gamma gene expression in CD8 T cells rather than inducing a shift to and/or increasing expression of IFN-gamma mRNA in other cell types. HIV+ subjects with increased PBMC IFN-gamma mRNA had elevated plasma levels of HIV RNA, neopterin, and beta 2-microglobulin. No differences in IFN-gamma mRNA levels were seen among HIV+ stratified by CD4 T cell number. Increased IFN-gamma may result from or be a contributing factor to increased viral load.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184702     DOI: 10.1006/cimm.1997.1115

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  9 in total

1.  Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients.

Authors:  P Brazille; N Dereuddre-Bosquet; C Leport; P Clayette; O Boyer; J-L Vildé; D Dormont; O Benveniste
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

Review 2.  Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection.

Authors:  J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

3.  Cytokine gene expression in normal human lymphocytes in response to stimulation.

Authors:  J Fan; P Nishanian; E C Breen; M McDonald; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

4.  Cytokine gene expression occurs more rapidly in stimulated peripheral blood mononuclear cells from human immunodeficiency virus-infected persons.

Authors:  E C Breen; M McDonald; J Fan; J Boscardin; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

5.  Enhanced interferon-gamma by CD8+ CD28- lymphocytes from HIV+ patients.

Authors:  E H Eylar; C Lefranc; I Báez; S L Colón-Martinez; Y Yamamura; N Rodriguez; N Yano; T B Breithaupt
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

6.  Generation of CD8(+) T-cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosis.

Authors:  E Liébana; R M Girvin; M Welsh; S D Neill; J M Pollock
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

7.  Immune determinants of organism and outcome in febrile hospitalized Thai patients with bloodstream infections.

Authors:  J Jason; L Archibald; L C McDonald; W M Hart; S Rheanppumikankit; S Tansuphwaswadikul; M G Byrd; J Larned; A Han; T A Green; W R Jarvis
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

8.  Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques.

Authors:  Kristina Abel; Lisa La Franco-Scheuch; Tracy Rourke; Zhong-Min Ma; Veronique De Silva; Beth Fallert; Laurel Beckett; Todd A Reinhart; Christopher J Miller
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  FIV infection of IL-2-dependent and -independent feline lymphocyte lines: host cells range distinctions and specific cytokine upregulation.

Authors:  D L Lerner; C K Grant; A de Parseval; J H Elder
Journal:  Vet Immunol Immunopathol       Date:  1998-10-23       Impact factor: 2.046

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.